Essentials in Stable Angina Pectoris
Published on 12. August 2016
Book
Paperback/Softback
XIII, 163 pages
978-3-319-41179-8 (ISBN)
Description
This title discusses the magnitude of the problem of angina pectoris. The author also goes on to describe the characteristics and clinical profile of patients with angina in a contemporary population.
The different types and multiple mechanisms of angina pectoris are described, while the clinical presentation, typical and atypical features and complications (MI, HF) and clinical management and outcomes are evaluated. The author also evaluates the various antianginal therapies used in special populations: the elderly, post revascularised patients, patients with LVSD or HF, patients with CKD, patients with diabetes.
The different types and multiple mechanisms of angina pectoris are described, while the clinical presentation, typical and atypical features and complications (MI, HF) and clinical management and outcomes are evaluated. The author also evaluates the various antianginal therapies used in special populations: the elderly, post revascularised patients, patients with LVSD or HF, patients with CKD, patients with diabetes.
More details
Edition
1st ed. 2016
Language
English
Place of publication
Cham
Switzerland
Publishing group
Springer International Publishing
Target group
Professional and scholarly
Illustrations
9 s/w Abbildungen, 23 farbige Abbildungen
XIII, 163 p. 32 illus., 23 illus. in color.
Dimensions
Height: 20.3 cm
Width: 12.7 cm
Weight
2227 gr
ISBN-13
978-3-319-41179-8 (9783319411798)
DOI
10.1007/978-3-319-41180-4
Schweitzer Classification
Other editions
Additional editions
Juan Carlos Kaski
Essentials in Stable Angina Pectoris
E-Book
08/2016
Springer
€53.49
Available for download
Person
Professor Juan-Carlos Kaski is Director of the Institute of Cardiovascular and Cell Sciences at St George's and Professor of Cardiovascular Science.
His main areas of research interest include therosclerosis (inflammatory and immunological mechanisms), mechanisms of rapid coronary artery disease progression, biomarkers of cardiovascular risk, microvascular angina and coronary artery spasm.
He provides consultancy in the following areas:
- Biomarkers of cardiovascular risk
- Atherosclerosis
- Angina pectoris
- Member of several advisory boards on pharmacotherapy and management of angina
- Advising several universities and funding bodies worldwide
Content
Epidemiology.- Pathophysiology.- Clinical presentation, typical and atypical features and complications.- Diagnostic investigations.- Non-pharmacological management of angina.- Pharmacological management.- Revascularization.- Cardiac rehabilitation.